Verve Therapeutics: A New Era in Cardiovascular Disease Treatment?

In a major breakthrough, Verve Therapeutics (VERV) has announced positive results from its Heart-2 clinical trial.…

MannKind Teams Up with Juncos Hollinger Racing (JHR) Driver Conor Daly to Drive Awareness of Diabetes and Innovative Treatment Options

MannKind Teams Up with Juncos Hollinger Racing (JHR) Driver Conor Daly to Drive Awareness of Diabetes…

Akeso's 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies

Akeso's 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies#Akeso039s #Results #Strengthening…

Soleno Therapeutics: A Breakthrough in Rare Disease Treatment

The biotech world is buzzing with excitement as Soleno Therapeutics (SLNO) has just received FDA approval…

Verve Therapeutics: HeFH Treatment Program Of VERVE-102 Remains On Track With 2025 Catalysts

Verve Therapeutics: HeFH Treatment Program Of VERVE-102 Remains On Track With 2025 Catalysts #Verve #Therapeutics #HeFH…

South Korea presses US commerce chief for favourable treatment on tariffs

South Korea presses US commerce chief for favourable treatment on tariffs#South #Korea #presses #commerce #chief #favourable…

Incyte: Still A ‘Buy’ Despite HS Treatment Data With Povorcitinib (NASDAQ:INCY)

This article was written by Follow Terry Chrisomalis is a private investor in the Biotech sector…

Hoth reports progress in GIST treatment with HT-KIT

Hoth reports progress in GIST treatment with HT-KIT#Hoth #reports #progress #GIST #treatment #HTKIT

Incyte reports pivotal trial success for HS treatment povorcitinib

Incyte reports pivotal trial success for HS treatment povorcitinib#Incyte #reports #pivotal #trial #success #treatment #povorcitinib

Akeso's Penpulimab Receives NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer

Akeso's Penpulimab Receives NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer#Akeso039s #Penpulimab #Receives #NMPA #Approval #FirstLine…

ZyVersa's Alzheimer's treatment shows promise in studies

ZyVersa's Alzheimer's treatment shows promise in studies#ZyVersa039s #Alzheimer039s #treatment #shows #promise #studies

SciSparc-Clearmind Collaboration Leads to Publication of Patent Application for Cocaine Addiction Psychedelic Combination Treatment in South Korea

SciSparc-Clearmind Collaboration Leads to Publication of Patent Application for Cocaine Addiction Psychedelic Combination Treatment in South…

Not all cancer patients need chemo — Ataraxis AI raised $20M to personalize treatment

Artificial intelligence is a big trend in cancer care, and it’s mostly focused on detecting cancer…

Faron's bexmarilimab receives FDA orphan drug status for MDS treatment

Faron's bexmarilimab receives FDA orphan drug status for MDS treatment#Faron039s #bexmarilimab #receives #FDA #orphan #drug #status…

DOGE’s HR email is getting the ‘Bee Movie’ spam treatment

Over the weekend, Elon Musk surveyed his followers on X — the platform he spent $44…

Cardiol Therapeutics reports heart failure treatment progress

Cardiol Therapeutics reports heart failure treatment progress#Cardiol #Therapeutics #reports #heart #failure #treatment #progress

Creative Medical enhances diabetes treatment with AI tech

Creative Medical enhances diabetes treatment with AI tech#Creative #Medical #enhances #diabetes #treatment #tech

US spells out life-saving HIV treatment that can continue during aid pause

US spells out life-saving HIV treatment that can continue during aid pause#spells #lifesaving #HIV #treatment #continue…

US government could seek over $1 billion from J&J for cancer treatment costs

US government could seek over $1 billion from J&J for cancer treatment costs#government #seek #billion #JampJ…

EU approves first long-acting HIV treatment for teens

EU approves first long-acting HIV treatment for teens#approves #longacting #HIV #treatment #teens

New breast cancer treatment has this tiny cap soaring

Good day, 360! Here are some of our top movers today. And if you love LOTTOS…

Scholar Rock: More Than Just SMA Biotech With Q2 2025 Obesity Treatment Data (NASDAQ:SRRK)

This article was written by Follow Terry Chrisomalis is a private investor in the Biotech sector…